1-(6-(Trifluoromethyl)pyridin-3-yl)cyclopropane-1-carbonitrile, 98%, 1g

4-(2-Methoxyphenyl)-1H-pyrazole, 250mg

5-ethyl-4-phenyl-1,3-thiazol-2-amine, 95.0%, 5g

5,6-Dibromo-1,10-phenanthroline, 95%, 1g

3-CYCLOBUTYL-1,2-OXAZOL-5-AMINE, 95.0%, 50mg

5-ACETYL-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE, 95.0%, 5g

N-(3,5-bis(trifluoromethyl)benzyl)-7,9-dimethyl-N-(2-methyl-2H-tetrazol-5-yl)-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine, 98%, 250mg

(S)-(-)-1-Phenyl-propan-1-ol, 98.0%, 250mg

(3-AMINO-6-METHYLPYRIDIN-2-YL)METHANOL, 95.0%, 250mg

Cartouches vides pour l'isolement des protéines FPLC, FPLC-30, 2 pièce(s)

Ethyl 6,8-dichlorooctanoate, 95.0%, 500g

N,N,N',N'-Tetrakis(4-nitrophenyl)-1,4-phenylenediamine>98.0%(N)1g

4-Bromo-2-chlorothiazole, 95.0%, 250mg